Thomas Gerlach

773 total citations
20 papers, 511 citations indexed

About

Thomas Gerlach is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Thomas Gerlach has authored 20 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Thomas Gerlach's work include Influenza Virus Research Studies (8 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (4 papers). Thomas Gerlach is often cited by papers focused on Influenza Virus Research Studies (8 papers), Viral Infections and Vectors (5 papers) and Mosquito-borne diseases and control (4 papers). Thomas Gerlach collaborates with scholars based in Germany, United States and Netherlands. Thomas Gerlach's co-authors include Guus F. Rimmelzwaan, Giulietta Saletti, Husni Elbahesh, Maija H. Zile, Gerd Sutter, Asisa Volz, Hans‐Dieter Klenk, Tatyana Matrosovich, Mikhail Matrosovich and Raja Atreya and has published in prestigious journals such as Hepatology, Cancer Research and Journal of Virology.

In The Last Decade

Thomas Gerlach

20 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gerlach Germany 12 199 185 157 155 72 20 511
Talitha Veith Germany 6 292 1.5× 227 1.2× 102 0.6× 77 0.5× 35 0.5× 8 556
Joshua Gillard Netherlands 9 180 0.9× 142 0.8× 108 0.7× 207 1.3× 39 0.5× 15 453
Carsten Kallfass Germany 6 199 1.0× 128 0.7× 263 1.7× 350 2.3× 54 0.8× 9 653
Åsa Hidmark Germany 14 239 1.2× 87 0.5× 106 0.7× 266 1.7× 51 0.7× 23 605
Elise S. Hovingh Netherlands 8 71 0.4× 145 0.8× 85 0.5× 146 0.9× 42 0.6× 10 372
Hideki Akeda Japan 14 94 0.5× 207 1.1× 58 0.4× 268 1.7× 55 0.8× 20 612
Aline dos Santos Moreira Brazil 13 167 0.8× 105 0.6× 155 1.0× 45 0.3× 65 0.9× 38 506
Maria Angela Biasolo Italy 16 182 0.9× 330 1.8× 216 1.4× 56 0.4× 35 0.5× 25 690
Gayle M. Boxx United States 8 211 1.1× 131 0.7× 232 1.5× 233 1.5× 15 0.2× 11 563
Anshu P. Gounder United States 10 184 0.9× 196 1.1× 196 1.2× 232 1.5× 21 0.3× 17 565

Countries citing papers authored by Thomas Gerlach

Since Specialization
Citations

This map shows the geographic impact of Thomas Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gerlach more than expected).

Fields of papers citing papers by Thomas Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gerlach. The network helps show where Thomas Gerlach may publish in the future.

Co-authorship network of co-authors of Thomas Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gerlach. A scholar is included among the top collaborators of Thomas Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gerlach. Thomas Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Prajeeth, Chittappen Kandiyil, Giulietta Saletti, Thomas Gerlach, et al.. (2024). Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerging Microbes & Infections. 13(1). 2373313–2373313. 2 indexed citations
3.
Puff, Christina, Thomas Gerlach, Wolfgang Baumgärtner, et al.. (2023). Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Frontiers in Immunology. 14. 9 indexed citations
4.
Puff, Christina, Thomas Gerlach, Wolfgang Baumgärtner, et al.. (2023). A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. Frontiers in Immunology. 14. 1182963–1182963. 8 indexed citations
5.
Gerlach, Thomas, et al.. (2020). Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines. 8(3). 451–451. 58 indexed citations
6.
Saletti, Giulietta, Thomas Gerlach, Husni Elbahesh, et al.. (2020). Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Scientific Reports. 10(1). 21447–21447. 47 indexed citations
7.
Elbahesh, Husni, Thomas Gerlach, Giulietta Saletti, & Guus F. Rimmelzwaan. (2019). Response Modifiers: Tweaking the Immune Response Against Influenza A Virus. Frontiers in Immunology. 10. 809–809. 15 indexed citations
8.
Gerlach, Thomas, et al.. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology. 119. 44–52. 113 indexed citations
9.
Gerlach, Thomas, Husni Elbahesh, Giulietta Saletti, & Guus F. Rimmelzwaan. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines. 18(4). 379–392. 19 indexed citations
10.
Elbahesh, Husni, Giulietta Saletti, Thomas Gerlach, & Guus F. Rimmelzwaan. (2018). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology. 34. 1–9. 24 indexed citations
11.
Saletti, Giulietta, Thomas Gerlach, & Guus F. Rimmelzwaan. (2018). Influenza vaccines: ‘tailor-made’ or ‘one fits all’. Current Opinion in Immunology. 53. 102–110. 10 indexed citations
12.
Gerlach, Thomas, Luca Hensen, Tatyana Matrosovich, et al.. (2017). pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs. Journal of Virology. 91(11). 52 indexed citations
13.
Auraß, Philipp, Thomas Gerlach, Dörte Becher, et al.. (2015). Life Stage-specific Proteomes of Legionella pneumophila Reveal a Highly Differential Abundance of Virulence-associated Dot/Icm effectors. Molecular & Cellular Proteomics. 15(1). 177–200. 29 indexed citations
14.
Gerlach, Katharina, Carolin Daniel, Hans A. Lehr, et al.. (2012). Transcription Factor NFATc2 Controls the Emergence of Colon Cancer Associated with IL-6–Dependent Colitis. Cancer Research. 72(17). 4340–4350. 52 indexed citations
15.
Gerlach, Thomas, Lena Kühling, Jennifer Uhlendorff, et al.. (2012). Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. Vaccine. 30(51). 7348–7352. 20 indexed citations
16.
18.
Gerlach, Thomas & Maija H. Zile. (1991). Effect of retinoic acid and apo‐RBP on serum retinol concentration in acute renal failure 1. The FASEB Journal. 5(1). 86–92. 25 indexed citations
19.
Zhou, Hui-Ren, Malford E. Cullum, Thomas Gerlach, Douglas A. Gage, & Maija H. Zile. (1991). Immunogens for the preparation of retinoic acid antibodies. The Journal of Nutritional Biochemistry. 2(3). 122–131. 4 indexed citations
20.
Gerlach, Thomas & Maija H. Zile. (1990). Upregulation of serum retinol in experimental acute renal failure. The FASEB Journal. 4(8). 2511–2517. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026